Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are common laboratory assessments for inflammation that often give concordant results. A computerized decision support rule against ESR/CRP co-ordering across a community health system led to a sustained 40% reduction in ESR/CRP co-ordering rates and an estimated annual payer cost savings of $15,000. These cost savings would represent one element of potential cost savings from new commercial multi-rule clinical decision support systems.
Describe the new knowledge and additional skills the participant will gain after attending your presentation.: Participants will learn about the performance characteristics of two common clinical assays for inflammation (ESR and CRP) and the opportunity for laboratory testing reduction in this clinical arena. Participants will learn about the ordering patterns for ESR and CRP and the financial impact of a single decision support rule against ESR/CRP test co-ordering across a community health system. Participants will learn how such analyses can help inform decisions about new commercial multi-rule clinical decision support systems.
Justin Juskewitch (Presenter)
Andrew Norgan, Mayo Clinic
Vipul Trivedi, Mayo Clinic Health System
Curtis Hanson, Mayo Clinic
Darci Block, Mayo Clinic